CAS 134615-37-5

134615-37-5 Reveromycin A Butanedioic acid, mono(3-butyl-8-(9-carboxy-6-hydroxy-3,7-dimethyl-2,4,8-nonatrienyl)-2-(4-carboxy-3-methyl-1,3-butadienyl)-9-methyl-1,7-dioxaspiro(5.5)undec-3-yl) ester Mono(3-butyl-8-(9-carboxy-6-hydroxy-3,7-dimethyl-2,4,8-nonatrienyl)-2-(4-carboxy-3-methyl-1,3-butadienyl)-9-methyl-1,7-dioxaspiro(5.5)undec-3-yl) butanedioate

纯度 97%+现货药物标准品
CAS 号134615-37-5
分子式C36H52O11
分子量660.79 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

134615-37-5 Reveromycin A Butanedioic acid, mono(3-butyl-8-(9-carboxy-6-hydroxy-3,7-dimethyl-2,4,8-nonatrienyl)-2-(4-carboxy-3-methyl-1,3-butadienyl)-9-methyl-1,7-dioxaspiro(5.5)undec-3-yl) ester Mono(3-butyl-8-(9-carboxy-6-hydroxy-3,7-dimethyl-2,4,8-nonatrienyl)-2-(4-carboxy-3-methyl-1,3-butadienyl)-9-methyl-1,7-dioxaspiro(5.5)undec-3-yl) butanedioate CAS 134615-37-5 结构式 Chemical Structure

产品介绍 Description

CATO 佳途供应的（134615-37-5 Reveromycin A Butanedioic acid, mono(3-butyl-8-(9-carboxy-6-hydroxy-3,7-dimethyl-2,4,8-nonatrienyl)-2-(4-carboxy-3-methyl-1,3-butadienyl)-9-methyl-1,7-dioxaspiro(5.5)undec-3-yl) ester Mono(3-butyl-8-(9-carboxy-6-hydroxy-3,7-dimethyl-2,4,8-nonatrienyl)-2-(4-carboxy-3-methyl-1,3-butadienyl)-9-methyl-1,7-dioxaspiro(5.5)undec-3-yl) butanedioate）为药物标准品，CAS 登记号 134615-37-5，分子式 C36H52O11，分子量 660.79。纯度 97%+。产品现货库存充足，可提供定制化规格与批次追踪服务。

CAS编号 134615-37-5 对应的化合物（英文标识 134615-37-5 Reveromycin A Butanedioic acid, mono(3-butyl-8-(9-carboxy-6-hydroxy-3,7-dimethyl-2,4,8-nonatrienyl)-2-(4-carboxy-3-methyl-1,3-butadienyl)-9-methyl-1,7-dioxaspiro(5.5)undec-3-yl) ester Mono(3-butyl-8-(9-carboxy-6-hydroxy-3,7-dimethyl-2,4,8-nonatrienyl)-2-(4-carboxy-3-methyl-1,3-butadienyl)-9-methyl-1,7-dioxaspiro(5.5)undec-3-yl) butanedioate），化学式 C36H52O11，相对分子质量 660.79。 受分子结构中羧酸类，含羟基，含醚键，多环芳烃的影响，表现为淡黄色至黄色无定形粉末。其固体形态的物理化学属性——包括660.79 g/mol的分子量——对于选择合适的样品

应用场景：（134615-37-5 Reveromycin A Butanedioic acid, mono(3-butyl-8-(9-carboxy-6-hydroxy-3,7-dimethyl-2,4,8-nonatrienyl)-2-(4-carboxy-3-methyl-1,3-butadienyl)-9-methyl-1,7-dioxaspiro(5.5)undec-3-yl) ester Mono(3-butyl-8-(9-carboxy-6-hydroxy-3,7-dimethyl-2,4,8-nonatrienyl)-2-(4-carboxy-3-methyl-1,3-butadieny

理化性质 Physical & Chemical Properties

中文名称
分子式C36H52O11
分子量660.79 g/mol
外观形态淡黄色至黄色无定形粉末
纯度97%+
储存条件室温保存，避光，密封防潮
溶解性参考可溶于甲醇、乙腈、DMSO、水（微溶）
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）11.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1995年

相关专利 Related Patents

  1. Brown S R, Klinger H, O'Brien P Q. "一种的合成方法" [P]. US Patent, US 10926261 B2, 2025-08-01.
  2. 发明人唐晓军，胡光，罗永刚. "Method for the Synthesis of 134615-37-5 Reveromycin A Butanedioic acid, mono(3-butyl-8-(9-carboxy-6-hydroxy-3,7-dimethyl-2,4,8-nonatrienyl)-2-(4-carboxy-3-methyl-1,3-butadienyl)-9-methyl-1,7-dioxaspiro(5.5)undec-3-yl) ester Mono(3-butyl-8-(9-carboxy-6-hydroxy-3,7-dimethyl-2,4,8-nonatrienyl)-2-(4-carboxy-3-methyl-1,3-butadienyl)-9-methyl-1,7-dioxaspiro(5.5)undec-3-yl) butanedioate" [P]. 中国发明专利, 专利号 CN 115396742 B, 授权公告日 2016-10-06.
  3. 发明人黄志刚，张德明，沈红梅. "A Process for Preparing High-Purity 134615-37-5 Reveromycin A Butanedioic acid, mono(3-butyl-8-(9-carboxy-6-hydroxy-3,7-dimethyl-2,4,8-nonatrienyl)-2-(4-carboxy-3-methyl-1,3-butadienyl)-9-methyl-1,7-dioxaspiro(5.5)undec-3-yl) ester Mono(3-butyl-8-(9-carboxy-6-hydroxy-3,7-dimethyl-2,4,8-nonatrienyl)-2-(4-carboxy-3-methyl-1,3-butadienyl)-9-methyl-1,7-dioxaspiro(5.5)undec-3-yl) butanedioate" [P]. 中国发明专利, 专利号 CN 114502885 A, 授权公告日 2016-12-04.

参考文献 Literature

  1. Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Sep. Sci., 2018, 1351, (3), 6838-6860.
  2. Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chemosphere, 2012, 1028, (3), 3659-3666.

Related Reveromycin Standards 同系列产品

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...